FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/11/2023
Back to search
Official data from USPTO
GP GETEIN BIOTECH, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
12/11/2023
Trademark type
Combined
Nice classes
5, 10
Filing date
11/17/2021
Registration date
08/22/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
08/22/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CN
Examiner
KLUWE, CHERYL D
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "GP GETEIN BIOTECH, INC.", "GP" formed by horizontal lines and appearing to the left of "GETEIN BIOTECH, INC.".
Holders and representatives
Holders
Getein Biotech, Inc.
Representatives
Timothy T. Wang NI, WANG & MASSAND, PLLC
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposesmedicines for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; biological preparations for medical purposespreparations for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; diagnostic preparations for medical purposes; biochemical preparations for medical usepreparations for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; Medicated serums for treatment of viral infectionsdiseases of the blood systemdiseases of the immune systemskin diseasesdiseases caused by bacterial exotoxinsbacterial infectionsfungal infectionsparasitic infections; chemical preparations for medical purposesfor cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; Drugs for medical purposes for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; Pharmaceutical preparations for the treatment of cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases; vaccines; dietetic substances adapted for medical use
Class 10
Diagnostic testing apparatus for testing blood sugar levelscancer cellsDNAsugarshormonesenzymeslipidsvitaminsinorganic ionselectrolytesdrugs and drug metabolitesautoantibodiesproteinsmicroorganismsDrug allergyallergensantigens of pathogenic pathogensantibodies of pathogenic pathogens and nucleic acids of pathogenic pathogensblood typetissue typehuman geneshereditary diseasesbiochemical indicatorsimmune function indicatorsnarcoticspsychotropic drugsToxic drugs for medical usetherapeutic drug targetstumor markers for medical purposes; diagnostic apparatus for use in medical analysis of blood; surgical apparatus and instruments; blood testing apparatus; galvanic therapeutic appliances for wound healing; Diagnostic apparatus for medical purposes for testing blood sugar levelscancer cellsDNAsugarshormonesenzymeslipidsvitaminsinorganic ionselectrolytesdrugs and drug metabolitesautoantibodiesproteinsmicroorganismsDrug allergyallergensantigens of pathogenic pathogensantibodies of pathogenic pathogens and nucleic acids of pathogenic pathogensblood typetissue typehuman geneshereditary diseasesbiochemical indicatorsimmune function indicatorsnarcoticspsychotropic drugsToxic drugs for medical usetherapeutic drug targetstumor markers; Medical apparatus and instrumentsfor cardiovascular diseasescardiovascular and cerebrovascular diseasescancerinfectious diseasesheart diseasesrespiratory diseasesimmune system diseaseskidney diseasesgastrointestinal diseasesdiabetescoagulation abnormalitiesblood system diseasesliver diseasestumortrace element deficiencyallergic diseasegenetic diseasegonadal diseasehormone disordervenereal diseasethyroid diseasebone diseasemetabolic diseasepancreatic diseaseinflammatory diseaseinorganic ion abnormalityelectrolyte abnormalityhand-foot-mouth diseasespecific protein abnormalitiespregnancy diseasesrheumatic diseasesdigestive system diseasesurinary system diseasesreproductive system diseasesendocrine diseasesmusculoskeletal diseasessexual dysfunctionneurological diseasesophthalmic diseasesskin diseasespsychiatric diseases diagnosis; urological apparatus and instruments for surgerydiagnostic testingtreatmentadjuvant therapy; X-ray apparatus for medical purposes
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/22/2023
FIMP
FINAL DISPOSITION PROCESSED
11/22/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/22/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/22/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/26/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/07/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/17/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/17/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/04/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/04/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/04/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/27/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/27/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/27/2023
RFNT
REFUSAL PROCESSED BY IB
11/21/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/03/2022
RFRR
REFUSAL PROCESSED BY MPU
11/03/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/10/2022
CNRT
NON-FINAL ACTION WRITTEN
09/09/2022
DOCK
ASSIGNED TO EXAMINER
08/29/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/11/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/07/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/06/2022
Continuous trademark protection
Get notified about every new filing that threatens GP GETEIN BIOTECH, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.